Categories Earnings, Others

Earnings Summary: Highlights of Prologis’ Q3 2023 results

Real estate investment trust Prologis, Inc. (NYSE: PLD) on Tuesday announced financial results for the third quarter of 2023, reporting higher revenues.

  • Net earnings per share declined to $0.80 in Q3 from $1.36 in the corresponding period of last year
  • Core funds from operations per share was $1.30, compared with $1.73 for the same period in 2022
  • Total revenues, meanwhile, increased to $1.92 billion in the three-month period from $1.75 billion a year earlier
  • Net earnings attributable to common stockholders was $746 million, down from $1.01 billion reported in Q3 2022
  • For fiscal 2023, the management expects earnings per share to be in the range of $3.30 to $3.35
  • Full-year core funds from operations are expected to be in the range of $5.58 per share to $5.60 per share

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top